Sign in
4

Changes in Ownership

Kodiak Sciences Inc. Filed Acc 0001754045-26-000002

Chief Financial Officer sold 30,000 shares at an average $39.92 ($1,197,488)

  • Chief Financial Officer acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Option exercise 10b5-1 +30,000 $1.04 $31,200 213,316 D: show line 1 in the form
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Sale 10b5-1 −12,692 $39.14 $496,765 200,624 D: show line 2 in the form
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Sale 10b5-1 −12,477 $40.29 $502,698 188,147 D: show line 3 in the form
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Sale 10b5-1 −4,231 $40.88 $172,963 183,916 D: show line 4 in the form
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Sale 10b5-1 −600 $41.77 $25,062 183,316 D: show line 5 in the form
Open-market sales · 30,000 sh · avg $39.92 · $1,197,488

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BORGESON JOHN A. Chief Financial Officer 2026-04-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −30,000 58,614 D: show line 6 in the form
Loading xslF345X06/form4-04032026_120417.xml…